Road toward rapid-molecular point of care test to detect novel SARS-coronavirus 2019 (COVID-19):: Review from updated literature

• S. Ahmad ^[1] ; N. Ali ^[1] ; M. Kausar ^[2] ; H. Misbah ^[3] ; A. Wahid ^[2]
  1. [1] College of Medical technology MTI- BKMC Mardan, Khyber Pakhtunkhwa, Pakistan
  2. [2] Rehman College of Allied Health Sciences, Peshawar, Khyber Pakhtunkhwa, Pakistan
  3. [3] North West General Hospital and Research Center, Peshawar, Khyber Pakhtunkhwa, Pakistan

  Mostrar afiliaciones +
• Localización: Allergologia et immunopathologia: International journal for clinical and investigate allergology and clinical immunology, ISSN-e 1578-1267, ISSN 0301-0546, Vol. 48, Nº. 5, 2020, págs. 518-520
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Coronavirus disease 2019 (COVID-19) named by the WHO as a result of the global public health emergency. COVID-19 is caused by a new coronavirus named as novel coronavirus (2019-nCOV). From the first case reported in December 2019 it is now a pandemic situation and a major public health emergency. The COVID-19 transmission rate is very high, infecting two to three persons on average with contact to an already infected person. There is a need for the health system, specially in developing countries such as in Pakistan, to combat such a novel disease by rapid, accurate, and high quality diagnostic testing in order to screen suspected cases and also surveillance of the disease. A rapid, accurate and low-cost diagnostic point-of-care device is needed for timely diagnosis of COVID-19 and is essential to combat such outbreaks for compelling preventive measures against the disease spread. This review is to highlight the importance of point-of-care diagnostics device for robust and accurate diagnosis of COVID-19 in physician offices and other urgent healthcare-type settings and encourage academics and stake holders towards advancement in order to control outbreaks and develop the public health surveillance system.